Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

BI building

Boehringer cuts R&D budget to €11bn to focus on collaborations

November 13, 2015 Medical Communications, Research and Development Boehringer Ingelheim

Boehringer Ingelheim has launched its new research and development strategy, committing €11 billion to R&D over the next five years. …
News
Proteus Digital and Otuska's 'digital pill'

The ‘Pharmasaurus’ aims to evolve into a leader in the digital age

November 12, 2015 Medical Communications, Research and Development Bayer, Roche, digital health, pharma

Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …
Feature
Benlysta

GSK ready for lupus drug push

November 12, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …
News

Astellas to acquire Ocata Therapeutics in $379m buyout

November 11, 2015 Research and Development, Sales and Marketing Astellas, Ocata, Stem cells, cell therapy, ophthalmology

Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …
News
roche

FDA approves Roche skin cancer combination

November 11, 2015 Research and Development, Sales and Marketing Cotellic, FDA, Genentech, Roche, Zelboraf, cobimetinib, melanoma, skin cancer, vemurafenib

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …
News
ABPI

UK ‘lacks the skills’ for future drug development, ABPI warns

November 11, 2015 Business Services, Research and Development ABPI, Jobs, careers, recruitment, skills gap

A shortage of skilled professionals threatens to undermine research and development of new medicines in the UK and prevent growth …
News
Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015 Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …
News

Lilly/Incyte RA drug bests Humira in Phase III trial

November 10, 2015 Research and Development Humira, baricitinib, lilly, phase III, rheumatoid arthritis

Eli Lilly says its investigational therapy baricitinib outperformed AbbVie’s Humira after 12 weeks in a late-stage study of people with …
News
ABPI

ABPI welcomes science budget inquiry findings

November 10, 2015 Manufacturing and Production, Research and Development ABPI, Comprehensive Spending Review

The UK pharma trade body, the ABPI, has welcomed the findings of the Science and Technology Committee’s inquiry into the …
News
Westminster

All Party Parliamentary Group for Life Sciences CSR letter to the Chancellor, Business Secretary and Science Ministers

November 10, 2015 Manufacturing and Production, Research and Development Chancellor, Comprehensive Spending Review, George Osborne

Dear Mr Osborne,Ahead of the forthcoming Comprehensive Spending Review I am sure you will have received many letters from across …
Feature
Janssen image

Janssen buys licence to diabetes and obesity drugs from Hanmi

November 10, 2015 Manufacturing and Production, Research and Development Janssen, diabetes, hanmi

Janssen could spend up to a billion dollars to buy for novel clinical stage biologics to treat diabetes and obesity. …
News
flu vaccine

Sanofi Pasteur ‘actively exploring’ universal flu vaccine

November 10, 2015 Manufacturing and Production, Research and Development SEEK, Sanofi Pasteur, influenza, universal flu vaccine

Sanofi Pasteur is developing a universal, cross-reactive antigen against seasonal and pandemic influenza, the company has revealed.The French firm presented its …
News

Health minister criticised for blocking Off-Patent Drugs Bill debate

November 9, 2015 Research and Development, Sales and Marketing Alistair Burt, Breast Cancer Now, MS Society, Off-Patent Drugs Bill

A Parliamentary Bill backing the wider use of off-patent drugs has been kicked into the long grass after the Government …
News
clinical trials

Governments and industry ‘combining to stall drug development’

November 9, 2015 Research and Development, Sales and Marketing BMJ, R&D, drug development

Both government and industry practices are responsible for the innovation deficit in the pharmaceutical sector, meaning that “the majority of …
News

UK doctors embracing technology, but not for their patients, survey reveals

November 6, 2015 Medical Communications, Research and Development

A global online survey of doctors released by market research agency Cello Health Insight has indicated that although UK doctors …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026